These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents. Pei Z. Curr Opin Drug Discov Devel; 2008 Jul; 11(4):512-32. PubMed ID: 18600568 [Abstract] [Full Text] [Related]
7. [A new therapeutic possibility for type 2 diabetes: DPP-4 inhibitors (sitagliptin)]. Abel T, Fehér J. Orv Hetil; 2010 Jun 20; 151(25):1012-6. PubMed ID: 20519186 [Abstract] [Full Text] [Related]
8. Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes. Tremblay AJ, Lamarche B, Deacon CF, Weisnagel SJ, Couture P. Diabetes Obes Metab; 2011 Apr 20; 13(4):366-73. PubMed ID: 21226820 [Abstract] [Full Text] [Related]